Frontlight ResearchEarly access
CompletedNo phase
A Feasibility Study Evaluating the Performance of Focused Multipolar Stimulation in Adult Cochlear Implant Recipients
Key facts
- Who runs it
- Cochlear
- Where
- Australia4 sites in 1 countryChoose a country to see its sites
- Trial code
- Status
- Completed
- People taking part
- 19 people enrolled
- Started
- 28 Nov 2022
- Ended
- 7 Apr 2025
- Type of study
- Interventional, 2 groupsOne group gets an existing treatment, for comparison.
- Treatments tested
- Focused stimulation strategy
- ACE stimulation strategy
- Record updated
- 10 April 2025
Who can take part
- Age
- 18 years and older
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 21 criteriaShow less
Who can take part
- Adults 18 years of age or older
- Candidate for unilateral cochlear implant with Slim Modiolar electrode array as determined by the implanting centre
- English spoken as a primary language
- Willingness to comply with all investigational requirements
- Willing and able to provide written informed consent
Who cannot take part
- Previous or existing cochlear-implant recipient
- Evidence of severe or greater sensorineural hearing loss prior to five years of age
- Unrealistic expectations on the part of the subject regarding the possible benefits, risks, and limitations that are inherent to the surgical procedure and prosthetic device
- Currently participating, or participated within the last 30 days, in another interventional clinical investigation/trial involving an investigational drug or device
- Medical or psychological conditions that would contraindicate undergoing surgery
- Duration of severe to profound hearing loss > 20 years in the ear to be implanted
- Open-set pre-operative word score > 70% in the contralateral ear
- Adults with functional acoustic hearing in the ear to be implanted who desire to use an acoustic component in the implanted ear
- Ossification or other cochlear anomaly that might prevent complete insertion of the electrode array
- Hearing loss of neural or central origin
- Women who are pregnant
- Additional handicaps that would prevent or restrict participation in the audiological evaluations
- Inability or unwillingness to use a hand-held device to control the sound processor and to collect test and survey data
- Unable or unwilling to comply with the requirements of the clinical investigation as determined by the Investigator
- Investigator site personnel directly affiliated with this study and/or their immediate families; immediate family is defined as a spouse, parent, child, or sibling
- Cochlear employees or employees of Contract Research Organisations or contractors engaged by Cochlear for the purposes of this investigation
Where is this trial?
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
This feasibility study is designed to explore several facets of hearing performance that may show improvements for alternative modes of stimulation compared to Monopolar (MP) stimulation within a group of adult cochlear-implant recipients. Measures of speech recognition, music appreciation, listening effort, quality of life, and real-world assessments will be gathered to determine the most promising benefits for further examination.
The 2 groups in the trial
- Adults cochlear implant recipients receiving alternative stimulation strategyTreatment being tested
ACE strategy, 8 maxima, alternative mode
Treatment: Focused stimulation strategy
- Adults cochlear implant recipients receiving Standard-of-Care stimulation strategy.Existing treatment, for comparison
ACE strategy, 8 maxima, monopolar mode.
Treatment: ACE stimulation strategy
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- A Feasibility, Prospective, Multi-centre, Repeated-measures Study Evaluating the Performance of Focused Multipolar Stimulation in Adult Cochlear Implant Recipients
- Record updated
- 10 April 2025